» Articles » PMID: 29677136

Cytoplasmic Translocation of Nucleolar Protein NOP53 Promotes Viral Replication by Suppressing Host Defense

Overview
Journal Viruses
Publisher MDPI
Specialty Microbiology
Date 2018 Apr 21
PMID 29677136
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

NOP53 is a tumor suppressor protein located in the nucleolus and is translocated to the cytoplasm during infection by vesicular stomatitis virus (VSV) and herpes simplex virus type 1 (HSV-1), as shown in our previous study. Cytoplasmic NOP53 interacts with the retinoic acid-inducible gene I (RIG-I) to remove its K63-linked ubiquitination, leading to attenuation of type I interferon IFN-β. In the present study, we found no obvious translocation of NOP53 in infection by a mutant virus lacking ICP4 (HSV-1/d120, replication inadequate). Blocking cytoplasmic translocation of NOP53 by the deletion of its nuclear export sequence (NES) abrogated its ability to support viral replication. These results demonstrated that NOP53 redistribution is related to viral replication. It is interesting that treatment with poly (I:C) or RIG-I-N (a constitutively-active variant) directly induced NOP53 cytoplasmic translocation. To better assess the function of cytoplasmic NOP53 in viral replication, the NOP53-derived protein N3-T, which contains a human immunodeficiency virus (HIV)-derived cell-penetrating Tat peptide at the C-terminal region of N3 (residues 330⁻432), was constructed and expressed. The recombinant N3-T protein formed trimers, attenuated the expression of IFN-β and IFN-stimulated genes, as well as decreased the phosphorylation level of interferon regulatory factor 3 (IRF3). Furthermore, N3-T promoted the efficient replication of enveloped and non-enveloped DNA and RNA viruses belonging to 5 families. Our findings expand the understanding of the mechanism by which viruses utilize the nucleolar protein NOP53 for optimal viral replication.

Citing Articles

Lytic Reactivation of the Kaposi's Sarcoma-Associated Herpesvirus (KSHV) Is Accompanied by Major Nucleolar Alterations.

Atari N, Rajan K, Chikne V, Cohen-Chalamish S, Doniger T, Orbaum O Viruses. 2022; 14(8).

PMID: 36016343 PMC: 9412354. DOI: 10.3390/v14081720.

References
1.
Okahara F, Ikawa H, Kanaho Y, Maehama T . Regulation of PTEN phosphorylation and stability by a tumor suppressor candidate protein. J Biol Chem. 2004; 279(44):45300-3. DOI: 10.1074/jbc.C400377200. View

2.
Dixit E, Kagan J . Intracellular pathogen detection by RIG-I-like receptors. Adv Immunol. 2013; 117:99-125. PMC: 3947775. DOI: 10.1016/B978-0-12-410524-9.00004-9. View

3.
Pan Y, Li R, Meng J, Mao H, Zhang Y, Zhang J . Smurf2 negatively modulates RIG-I-dependent antiviral response by targeting VISA/MAVS for ubiquitination and degradation. J Immunol. 2014; 192(10):4758-64. DOI: 10.4049/jimmunol.1302632. View

4.
Carty M, Reinert L, Paludan S, Bowie A . Innate antiviral signalling in the central nervous system. Trends Immunol. 2013; 35(2):79-87. DOI: 10.1016/j.it.2013.10.012. View

5.
Liu Y, Goulet M, Sze A, Bel Hadj S, Belgnaoui S, Lababidi R . RIG-I-Mediated STING Upregulation Restricts Herpes Simplex Virus 1 Infection. J Virol. 2016; 90(20):9406-19. PMC: 5044816. DOI: 10.1128/JVI.00748-16. View